Blog Post

CMS Receives New Permissive Exclusion Authority: What Healthcare Organizations Should Know

Suzanne Castaldo | November 2026

On October 14, 2026, the Department of Health and Human Services (HHS) formally delegated authority to impose permissive exclusions from federal healthcare programs to the Administrator of the Centers for Medicare & Medicaid Services (CMS). Historically, exclusion authority has been exercised primarily by the HHS Office of Inspector General (OIG). The new delegation gives CMS authority to impose permissive exclusions while preserving OIG’s existing authority. 

On October 27, 2026, OIG published additional guidance clarifying how the agencies will exercise their respective responsibilities.

Section 1128 of the Social Security Act establishes circumstances under which individuals and entities may be excluded from federal healthcare programs. 

Certain exclusions are mandatory, meaning exclusion is required when specified statutory conditions are met. Others are permissive, allowing government discretion to determine whether exclusion is appropriate.

Permissive exclusion authority applies to various circumstances, including certain criminal convictions, licensing actions, submission of false or fraudulent claims, and other conduct specified in federal law. 

Exclusion can have substantial consequences. Federal healthcare programs generally will not pay for items or services furnished, ordered, or prescribed by excluded individuals or entities, including certain services provided indirectly through other organizations.

The October 14 delegation gives CMS authority under Section 1128(b) of the Social Security Act. It does not diminish OIG’s existing authority or establish new statutory grounds for exclusion. HHS explained that CMS is positioned to investigate and develop evidence supporting exclusion determinations because of its responsibility for administering Medicare and Medicaid. 

The delegation became effective immediately but does not include authority to conduct hearings or issue regulations.

In updated FAQs published October 27, 2026, OIG addressed several questions concerning the new delegation, including:

  • Mandatory exclusions remain with OIG. CMS’s new authority applies only to permissive exclusions. OIG will continue to impose mandatory exclusions. 
  • OIG will resolve exclusion authority in False Claims Act Settlements (FCA). Organizations negotiating FCA settlements with the Department of Justice will not need to separately negotiate CMS’s permissive exclusion authority. OIG confirmed that it will resolve HHS permissive exclusion authority in these matters.
  • Coordination between CMS and OIG remains under development. OIG indicated that the agencies would continue working together but has not provided details regarding how exclusion matters will be allocated.
  • Public reporting procedures are not yet finalized. OIG is coordinating with CMS to make all exclusions publicly available. However, implementation details, including how CMS-imposed exclusions will appear in public databases, remain under development. 

The delegation expands CMS’s enforcement authority and may affect how certain healthcare investigations and administrative enforcement matters are handled. The clarification concerning FCA settlements is particularly important because it provides greater certainty about how exclusion authority will be addressed in those resolutions. 

The delegation does not, by itself, change existing exclusion screening requirements.  Compliance officers should monitor future guidance concerning the publication of CMS exclusions and any resulting implications for screening procedures. 

Organizations should also consider CMS’s expanded authority when evaluating significant compliance concerns and assessing potential administrative enforcement exposure. 

CMS’s new permissive exclusion authority represents a meaningful change in federal healthcare enforcement. OIG’s subsequent guidance resolves some immediate questions, particularly regarding mandatory exclusions and FCA settlements, while leaving important implementation details unanswered. 

Healthcare organizations should understand the expanded enforcement authority and monitor how CMS and OIG implement their respective responsibilities.

For more information on this topic, please contact Suzanne Castaldo at [email protected].

About the Author

Suzanne Dallas Castaldo, JD, is a certified Healthcare Compliance Professional (CHC, CHPC), qualified in the development, implementation, and evaluation of compliance programs for the health care industry. She has assisted a variety of health care providers including hospitals, physician practice groups, skilled nursing facilities, clinical laboratories, managed care organizations, and pharmacies.

Subscribe to blog